国产精品久久久久久永久牛牛,55国产福利在线视频,成人午夜精品视频在线观看

至今，GenScript的服務及產品已被Cell, Nature, Science, PNAS等1300多家生物醫(yī)藥類雜志引用近萬次，處于行業(yè)領先水平。NIH、哈佛、耶魯、斯坦福、普林斯頓、杜克大學等約400家全球著名機構使用GenScript的基因合成、多肽服務、抗體服務和蛋白服務等成功地發(fā)表科研成果，再次證明GenScript 有能力幫助業(yè)內科學家Make research easy.

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial

Vaccines (Basel). 2023-02; 
Aleksandr V Kudriavtsev, Anna V Vakhrusheva, Nickolay A Kryuchkov, Maria E Frolova, Konstantin A Blagodatskikh, Taras V Ivanishin, Milana Djonovic, Ekaterina A Romanovskaya-Romanko, Anton N Kovalenko, Dmitry A Lioznov, Tatiana G Zubkova, Svetlana V Teplykh, Rodion A Oseshnyuk, Marina A Stukova, Artur A Isaev, Igor V Krasilnikov
Products/Services Used Details Operation
Proteins, Expression, Isolation and Analysis … ) (GenScript, Piscataway, New Jersey, US) that was used in this study. There is a good correlation between PRNT values and the binding inhibition values obtained with GenScript’s … Get A Quote

摘要

關鍵詞

Betuvax-CoV-2, COVID-19, SARS-CoV-2, betulin, clinical trial, subunit vaccine
Article Link > 
      

        

              
主站蜘蛛池模板：
新平|
罗田县|
巴塘县|
大英县|
格尔木市|
常熟市|
吉木萨尔县|
衡阳县|
兴化市|
济宁市|
花垣县|
洞头县|
武功县|
蓬溪县|
祥云县|
黄大仙区|
方山县|
普宁市|
齐齐哈尔市|
宁河县|
保山市|
遵义市|
泸州市|
永康市|
湘潭市|
延边|
芜湖市|
江北区|
苍梧县|
中西区|
溧阳市|
塔城市|
白水县|
富蕴县|
高邮市|
若羌县|
增城市|
淄博市|
巴里|
公主岭市|
江达县|